Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) (AMIRA)

Clinical Trial ID NCT04095988

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04095988

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Functional bowel disorders. Gastroenterology 2006 20.72
2 Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013 20.65
3 Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012 4.78
4 Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014 3.66
5 Postinfectious irritable bowel syndrome. Gastroenterology 2009 3.17
6 Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2012 2.60
7 Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 2007 2.38
8 Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010 2.23
9 Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989 2.16
10 Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002 1.97
11 Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012 1.87
12 Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. Gastroenterology 2013 1.86
13 High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 2013 1.85
14 Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010 1.62
15 Long-term monitoring of the human intestinal microbiota composition. Environ Microbiol 2012 1.26
16 Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil 2011 1.14
17 The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil 2013 1.03
18 Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol 2014 1.00
19 Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome. Z Gastroenterol 2011 0.86
20 Fecal transplant in refractory Clostridium difficile colitis. Dtsch Arztebl Int 2013 0.83
21 [S3 guideline of the German Society for Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM) to the definition, pathophysiology, diagnosis and treatment of intestinal motility]. Z Gastroenterol 2011 0.80
22 [Functional and inflammatory bowel disorders]. Med Klin (Munich) 2006 0.75
Next 100